Recuren Plus Face Cream
NDC Package 87014-005-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Recuren Plus Face Cream (salicylic acid 0.5%, zinc pyrithione 0.25%) cream is a gentle antifungal face cream designed for daily care of sensitive skin prone to seborrheic dermatitis, fungal ance, folliculitis & Mild Psoriasis. This formulation utilizes a cream delivery system. Marketed by Regeneren Plus Ltd, this product is identified by NDC 87014-005 and is authorized under FDA application M032.

Identification & Billing

NDC Package Code
87014-005-01
Package Description
100 g in 1 CARTON
Product Code
87014-005
11-Digit Billing Format
87014000501

Clinical Specifications

Proprietary Name
Recuren Plus Face Cream
Non-Proprietary Name
Salicylic Acid 0.5%, Zinc Pyrithione 0.25%
Substance Name
Salicylic Acid; Zinc Pyrithione
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
A gentle antifungal face cream designed for daily care of sensitive skin prone to seborrheic dermatitis, fungal ance, folliculitis & Mild Psoriasis.

Regulatory & Marketing

Labeler Name
Regeneren Plus Ltd
Product Type
Human Otc Drug
FDA Application #
M032
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-13-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87014-005-01 identifies a specific commercial package of 100 g in 1 carton of Recuren Plus Face Cream, a human over the counter drug labeled by Regeneren Plus Ltd. This cream is formulated for topical use and contains salicylic acid; zinc pyrithione as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Regeneren Plus Ltd on May 13, 2026. The current certification is valid through December 31, 2027.

How is this Regeneren Plus Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87014000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87014-005-01
11-Digit CMS (5-4-2)
87014-0005-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.